Evidence map›Paper›PMID 35885894›Full record

ArticleGenes2022

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy.

Kristina Jevnikar, Luka Lapajne, Daniel Petrovič, Andrej Meglič, Mateja Logar, Nataša Vidovič Valentinčič, Mojca Globočnik Petrovič, Ines Cilenšek, Polona Jaki Mekjavić

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Delving Into the Depths ofHuman mutation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kristina JevnikarDepartment of Ophthalmology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0001-9688-0601
Luka LapajneDepartment of Ophthalmology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Daniel PetrovičLaboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0001-6637-2542
Andrej MegličDepartment of Ophthalmology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Mateja LogarDepartment of Infectious Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Nataša Vidovič ValentinčičDepartment of Ophthalmology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Mojca Globočnik PetrovičDepartment of Ophthalmology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Ines CilenšekLaboratory for Histology and Genetics of Atherosclerosis and Microvascular Diseases, Institute of Histology and Embryology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Polona Jaki MekjavićDepartment of Ophthalmology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-1949-4525
University of Ljubljana · SILjubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proposed SARS-CoV-2-induced dysregulation of the renin-angiotensin-aldosterone (RAAS) system results in endothelial dysfunction and microvascular thrombosis. The retinal plexuses contain terminal vessels without anastomotic connections, making the retina especially susceptible to ischemia. This study aimed to determine the role of selected polymorphisms of genes in the RAAS pathway in COVID-19 severity and their association with the presence of COVID-19 retinopathy. 69 hospitalized patients in the acute phase of COVID-19 without known systemic comorbidities and 96 healthy controls were enrolled in this prospective cross-sectional study. The retina was assessed with fundus photography using a Topcon DRI OCT Triton (Topcon Corp., Tokyo, Japan) in the COVID-19 unit. Genotyping of selected polymorphisms in the genes for ACE (rs4646994), ACE2 (rs2285666), and AGTR2 (rs1403543) was performed. The COVID-19 group was divided into mild (

Indexed as

COVID-19Retinal DiseasesAngiotensin-Converting Enzyme 2Cross-Sectional StudiesHumansMalePeptidyl-Dipeptidase APolymorphism, GeneticProspective StudiesReceptor, Angiotensin, Type 2SARS-CoV-2ACE2 protein, humanACE protein, humanAGTR2 protein, humanAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AReceptor, Angiotensin, Type 2angiotensin-converting enzymeangiotensin-converting enzyme 2angiotensin II receptor type 2COVID-19polymorphismretina

Identifiers

PMID35885894
PMCPMC9318051
OpenAlexW4283270107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.